Events and training
line
BD at WoCoVA 2024
line
Facebook LinkedIn Emailline
Contact Us

BD at WoCoVA 2024

Join us at the 8th World Congress on Vascular Access (WoCoVA). We’re bringing together a world-class cast of vascular access experts.

Vascular access excellence, wherever the patient is: strategies for improving patient care and reducing costs with outside hospital care

Wednesday, 17th April, 11:15 a.m. – 12:00 p.m.
1st day of WoCoVA
Prague Congress Centre

A reflection on the challenges and benefits of an OPAT service in Swansea Bay Health Board

Frankie Thompson, Lead Nurse Vascular Access and Outpatient parenteral antibiotic therapy (OPAT), Swansea Bay University Hospital, Wales, United Kingdom

Healthcare provision is currently undergoing significant transformation due to several factors, including an ageing population, rising prevalence of chronic diseases and resource constraints.1,2 Governments and healthcare organisations are actively exploring new models for delivering care.1 One key focus area is shifting healthcare provision outside the traditional hospital-based acute care setting.3

This symposium will spotlight an innovative approach to healthcare delivery that leverages the expertise of hospital infusion: OPAT. Since it was implemented in the United Kingdom in the 1990s,4 OPAT has gained broader adoption across Europe, including in Switzerland and Germany.5,6

By allowing patients to receive antimicrobial treatment without the need to stay in hospital, OPAT has been shown to improve patient outcomes, while reducing strain on hospital resources.4

Humanisation of care, a new era: home-vascular access service

Dr Monica Pinto, Director, Rehabilitative Medicine Department, Scientific Institute for Research, Hospitalisation and Healthcare (IRCCS), National Cancer Institute, G Pascale Foundation, Naples, Italy

Moderator: Stephen Church, Director Medical and Clinical Affairs, BD Medication Delivery Solutions (MDS), Europe, Middle East and Africa (EMEA)

Dr Pinto will show how healthcare professionals can support caregivers by empowering them to play a more active role in the care, maintenance and monitoring of the patient’s vascular access. Technology can support them by providing remote assistance for effective communication with the hospital team.

By enabling patients to be managed at home, this approach represents a positive shift toward patient-centred care and more efficient resource utilisation.

After these presentations, you’ll understand how:

  1. Vascular access plays an important role in managing patient care outside of the normal acute care hospital environment, which has advantages for the patient and the healthcare system.
  2. Vascular access can be used in an outpatient setting to effectively deliver antimicrobial therapy
  3. Technology can help to empower, enable and support caregivers to provide vascular access management at home.

Advances in vascular access technology: how technology can help you to improve patient care and experience

Thursday, 18th April, 11:25 a.m. – 12:10 p.m.
2nd day of WoCoVA
Prague Congress Centre 

Strategies for preventing catheter related thrombosis in 2024

Dr Mauro Pittiruti, Surgeon, Catholic University Hospital, Rome​, Italy

Catheter-related thrombosis in vascular access is frequently encountered, yet the precise causes remain somewhat elusive due to the number of factors that may influence it.7 Catheter-related thrombosis often leads to premature catheter removal.7

Our first speaker will delve into the key factors contributing to these events, specifically how device choice and insertion technique are crucial factors in minimising catheter-related thrombosis. Practical guidance on avoiding such complications will be provided.

After this presentation, you’ll understand:

  1. The importance of choice of device in the prevention of catheter-related thrombosis
  2. The importance of insertion techniques in the prevention of catheter-related thrombosis

How strong collaboration between healthcare professionals and product development teams improves patient care and experience

Shayne Messerly, Director of Innovation, BD Medication Delivery Systems

Moderator: Servane Pelle, Associate Director Medical and Clinical Affairs, BD MDS, Europe, EMEA

REGISTER FOR WOCOVA

We’ll see you in Prague at WoCoVA!

References

  1. PricewaterhouseCoopers (PwC). Transformation in healthcare: A prescription to address the rapidly changing health ecosystem. Published online 2019. Accessed March 5, 2024. https://www.pwc.com/gx/en/industries/healthcare/publications/transformation-in-healthcare.html
  2. World Health Organisation (WHO). Ageing and health. Published October 1, 2022. Accessed March 5, 2024. https://www.who.int/news-room/fact-sheets/detail/ageing-and-health
  3. Omboni S, Padwal RS, Alessa T, et al. The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future. Connect Health. 2022;1:7-35. doi:10.20517/ch.2021.03
  4. Chapman ALN, Patel S, Horner C, Gilchrist M, Seaton RA. Outpatient parenteral antimicrobial therapy: updated recommendations from the UK. J Antimicrob Chemother. 2019;74(11):3125-3127. doi:10.1093/jac/dkz343
  5. Scholten N, Leisse C, Brandes V, et al. Outpatient parenteral antimicrobial therapy in Germany: a prospective cohort study protocol. BMJ Open. 2022;12(11):e061417. doi:10.1136/bmjopen-2022-061417
  6. Erba A, Beuret M, Daly ML, Khanna N, Osthoff M. OPAT in Switzerland: single-center experience of a model to treat complicated infections. Infection. 2020;48(2):231-240. doi:10.1007/s15010-019-01381-8
  7. Wall C, Moore J, Thachil J. Catheter-related thrombosis: A practical approach. J Intensive Care Soc. 2016;17(2):160-167. doi:10.1177/1751143715618683
  8. Sharp R, Carr P, Childs J, et al. Catheter to vein ratio and risk of peripherally inserted central catheter (PICC)-associated thrombosis according to diagnostic group: a retrospective cohort study. BMJ Open. 2021;11(7):e045895. doi:10.1136/bmjopen-2020-045895
  9. Bard PowerMidlineTM Catheter. Instruction For Use. May 2017. 0745353 1705R.
  10. Bard Provena Midline Instruction For Use. October 2018. 0745751 1810R.

 

This list of references to third-party peer-reviewed material and the sites they are hosted on are provided for your reference and convenience only, and do not imply any review or endorsement of the material or any association with their operators.  The Third-Party References (and the Web sites to which they link) may contain information that is inaccurate, incomplete, or outdated. Your access and use of the Third Party Sites (and any Web sites to which they link) is solely at your own risk.

The presentations developed by the presenters, and the findings, interpretations, and conclusions contained or expressed within them do not necessarily reflect the views of BD. To the extent these presentations relate to specific products, such products should always be used in accordance with the relevant instructions for use and other product documentation.

*Please note a full abstract will be provide once this overview is accepted by the scientific committee of WoCoVA.

BD-117659